The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

Published:2011 Issue:6 Volume:16 Page:265
ISSN:2047-783X
Container-title:European Journal of Medical Research
language:en
Short-container-title:Eur J Med Res

Author:

Matuschek C,Bölke E,Peiper M,Knoefel WT,Budach W,Erhardt A,Scherer A,Gerber PA,Buhren BA,Gattermann N,Baldus SE,Rusnak E,Shukla V,Orth K

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference38 articles.

1. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

2. Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials

3. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

4. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

5. A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and Recurrence Patterns in Patients With Stomach Adenocarcinoma Receiving Chemotherapy or Chemoradiotherapy After D2 Gastrectomy in a Tertiary Care Cancer Institute: A Retrospective Real-World Evidence Cohort Study;Advances in Radiation Oncology;2023-11

2. Aurora kinase: An emerging potential target in therapeutics;Protein Kinase Inhibitors;2022

3. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity;Strahlentherapie und Onkologie;2020-02-13

4. Validation of Malayalam translation of the European organization for the research and treatment of cancer quality of life instrument OG25 for esophagogastric junction cancers;Indian Journal of Palliative Care;2020

5. Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis;Journal of Cancer;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3